Jump to content


Congrats to Margaret, Platinum Member with 1,000 posts and 10 Years of Forums Membership!


Photo

Treatment of patients with destructive arthritis with certolizumab pegol


  • Please log in to reply
No replies to this topic

#1 GocartMoz

GocartMoz

    Silver Member

  • Members
  • PipPipPipPip
  • 164 posts
  • Location:Florida

Posted 25 June 2010 - 03:25 AM

Treatment of patients with destructive arthritis with certolizumab pegol. Certolizumab pegol is a new anti-TNF-alpha inhibitor which has been approved for the treatment of rheumatoid arthritis since October 2009. In two individual case reports a remission of therapy refractive arthritis was achieved by administration of certolizumab pegol. (SpringerLink) T. Schmeiser. Zeitschrift fur Rheumatologie. June 9 2010. (Also see: Treatments for RAand TNF Inhibitors)

This item was posted in the ISN Newsroom. Check the Newsroom every day for the latest scleroderma medical and support information.